Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Windtree Therapeutics
About
Windtree is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.
- 101 - 250
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.90M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Wellness
- Founded date
- Nov 1, 1992
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Windtree Therapeutics (formerly Discovery Laboratories) is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant — and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree is focused initially on improving the management of respiratory distress syndrome (RDS) in premature infants and believes that its proprietary technology may make it possible, over time, to develop a pipeline of KL4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 22, 2018 | Grant | $700K | 1 |
National Institutes of Health
|
— | Detail |
| Oct 1, 2014 | Grant | $3M | 1 | — | — | Detail |
| Jun 17, 2014 | Grant | $1.90M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
